Publication
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
dc.contributor.author | Nguyen, T | |
dc.contributor.author | Qureshi, M | |
dc.contributor.author | Klein, P | |
dc.contributor.author | Yamagami, H | |
dc.contributor.author | Abdalkader, M | |
dc.contributor.author | Mikulik, R | |
dc.contributor.author | Sathya, A | |
dc.contributor.author | Mansour, O | |
dc.contributor.author | Czlonkowska, A | |
dc.contributor.author | Lo, H | |
dc.contributor.author | Field, T | |
dc.contributor.author | Charidimou, A | |
dc.contributor.author | Banerjee, S | |
dc.contributor.author | Yaghi, S | |
dc.contributor.author | Siegler, J | |
dc.contributor.author | Sedova, P | |
dc.contributor.author | Kwan, J | |
dc.contributor.author | Aguiar de Sousa, D | |
dc.contributor.author | Demeestere, J | |
dc.contributor.author | Inoa, V | |
dc.contributor.author | Omran, S | |
dc.contributor.author | Zhang, L | |
dc.contributor.author | Michel, P | |
dc.contributor.author | Strambo, D | |
dc.contributor.author | Marto, JP | |
dc.contributor.author | Nogueira, R | |
dc.date.accessioned | 2023-08-25T14:59:29Z | |
dc.date.available | 2023-08-25T14:59:29Z | |
dc.date.issued | 2022-05 | |
dc.description.abstract | Background and purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | J Stroke . 2022 May;24(2):256-265. | pt_PT |
dc.identifier.doi | 10.5853/jos.2022.00752 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4662 | |
dc.language.iso | eng | pt_PT |
dc.publisher | Korean Stroke Society | pt_PT |
dc.subject | HSJ NEU | pt_PT |
dc.subject | COVID-19 | pt_PT |
dc.subject | Cerebral venous thrombosis | pt_PT |
dc.subject | SARS-CoV-2 | pt_PT |
dc.subject | Mortality | pt_PT |
dc.subject | Stroke | pt_PT |
dc.subject | Vaccine-Induced Immune Thrombotic Thrombocytopenia | pt_PT |
dc.title | Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 265 | pt_PT |
oaire.citation.issue | 2 | pt_PT |
oaire.citation.startPage | 256 | pt_PT |
oaire.citation.title | Journal of Stroke | pt_PT |
oaire.citation.volume | 24 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |